News
Should We Bring CAR-T Therapy Home Sooner?
Chimeric Antigen Receptor (CAR) T-cell therapy is already making a significant impact in treating various blood cancers, including multiple myeloma. Currently, two CAR T-cell therapies
I’d love to hear from you!
Chimeric Antigen Receptor (CAR) T-cell therapy is already making a significant impact in treating various blood cancers, including multiple myeloma. Currently, two CAR T-cell therapies
Dan Buettner, author of a book on the world’s famed “Blue Zones” where people live remarkably long lives, recently hosted an intimate dinner party in
On Friday, March 15, 2024; the U.S. Food and Drug Administration (FDA) held an Oncologic Drugs Advisory Committee (ODAC) meeting to assess the risk-benefit profile
